Novel Lupus Drug Clears Phase II Hurdle

(MedPage Today) -- BARCELONA -- A small-molecule oral drug shaping up as a first-in-class to treat various forms of lupus performed well in a phase II trial, despite -- or perhaps even because of -- missing its primary endpoint, a presentation...